Optieum Biotechnologies
PrivateLast Round
Grant
Mar 18, 2025
Total Funding Raised
$11.09M
Company Overview
Optieum Biotechnologies is a biotechnology company that develops antibody-based therapies intended to treat cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optieum Biotechnologies Comparables
Compare Optieum Biotechnologies with similar companies based on industry and business-model similarity.
Optieum Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2025 | ||||
| Series A | Jan 14, 2025 | ||||
| Grant | Jan 27, 2022 | ||||
| Seed | Sep 30, 2021 |
Key People
Founding team and executive leadership
Optieum Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| Saisei Ventures | Series A |
| Kobe University Capital | Series A |
| Keio Innovation Initiative | Series A |
| Iyogin Capital Company Limited | Series A, Seed |
| New Energy and Industrial Technology Development Organization | Grant |
| ANRI株式会社 | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2025
Monthly visitors grew 461% MoM, reaching 3.3K.
- Mar 18, 2025
$39M grant from Japan Agency for Medical Research and Development.
Optieum Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Optieum Biotechnologies's valuation, stock price, and market status.